We again found that human IFITMs inhibit SARS‐CoV‐2 infection, though effects of transiently transfected IFITM2 did not reach statistical significance (Fig 3C and D ).
1
—
—
We again found that human IFITMs inhibit SARS‐CoV‐2 infection, though effects of transiently transfected IFITM2 did not reach statistical significance (Fig 3C and D ).